AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2018
Mar 2, 2018
30826_dirs_2018-03-02_325bb9ce-c858-46f7-9892-63a9097dec3a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2018-02-28
Reporting Person: Hunt Anthony (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common Stock | F | 8825 | $34.9066 | Disposed | 74788 | Direct |
Footnotes
F1: Payment of tax liability made via forfeiture of 8,825 shares of Common Stock valued at a weighted average price of $34.9066 per share on February 28, 2018.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23